The FDA’s proposed ‘very low nicotine’ standard has a very low chance of helping
If conventional cigarettes are banned, many consumers would turn to the black market rather than settle for legal very low ...
Scientific American7d
What’s in ZYN, the FDA-Authorized Nicotine Pouch? Is It Harmful?
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
Medscape8d
FDA Proposes Cap on Nicotine in Cigarettes, Other Tobacco Products
The FDA is proposing a limit on the amount of nicotine in cigarettes and certain other combustible tobacco products to reduce ...
IFLScience11d
FDA Authorizes Marketing For Nicotine Pouches For First Time – What Does This Mean?
After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.
Healio13d
FDA approves sale of Zyn nicotine pouches following extensive review
The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.
The American Journal of Managed Care10d
In a First-of-Its-Kind Decision, FDA Will Allow Marketing of Nicotine Pouches
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...
phillyvoice.com13d
The FDA wants to limit nicotine in cigarettes — a move that could save millions of lives
Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it ...
The Healthy on MSN10d
The FDA Wants To Shrink Nicotine Content in These 5 Products
First recommended by a Trump-appointed FDA leader, multiple administrations have collaborated to snuff out this issue that ...
FDA makes key decision on Zyn nicotine pouches
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
SCOTUSblog7d
Menthol vapes and forum shopping, FDA tobacco control comes before justices
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...